BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 22
• 23
• 24
• 25
• 28

• Business

  West Pharmaceutical Services Appoints Two Directors and Announces Second Quarter 2011 Dividend

  February 24, 2011

   · 

  2 min read
• PROLOR Biotech to Present at 2011 Citi Global Healthcare Conference

  February 24, 2011

   · 

  1 min read
• Business

  Symmetry Medical Inc. Reports Fourth Quarter and Full Year 2010 Financial Results

  February 24, 2011

   · 

  8 min read
• Drug Development

  Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer

  February 24, 2011

   · 

  9 min read
• Biotech Beach

  Questcor Pharmaceutical, Inc. (Carlsbad, CA) to Present at Upcoming Investor Conferences

  February 24, 2011

   · 

  1 min read
• Business

  HeartWare Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009

  February 24, 2011

   · 

  7 min read
• BioMidwest

  ZeaVision, LLC’s EyePromise(R) EZ Tears Attacks Dry Eye from the Inside

  February 24, 2011

   · 

  2 min read
• Pharm Country

  Pozen, Inc. Migraine Drug Fails to Get Patent Extension

  February 24, 2011

   · 

  1 min read
• FDA

  Scarguard Labs, LLC Gains Approval to Sell Scarguard in Canada from Health Canada

  February 24, 2011

   · 

  1 min read
• Biotech Beach

  Ardea Biosciences, Inc. Announces Exercise in Full of Overallotment Option for Common Stock Offering

  February 24, 2011

   · 

  3 min read